Q2 2024 · 13F-HR
Tri Locum Partners LPholdings as filed
Filed 2024-08-14 · accession 0001826434-24-000006
$395.5M
Reported value
25
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $41.4M | 10.5% | 2,550,307 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $32.1M | 8.11% | 74,558 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $31.1M | 7.85% | 227,762 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $25.7M | 6.50% | 82,271 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $25.0M | 6.31% | 230,585 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $24.7M | 6.24% | 306,513 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $21.2M | 5.36% | 316,501 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $19.9M | 5.02% | 335,514 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $18.4M | 4.65% | 17,516 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $18.3M | 4.63% | 65,352 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $17.8M | 4.51% | 133,276 | Common | SOLE |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $16.7M | 4.23% | 1,189,518 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $16.7M | 4.22% | 596,919 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $16.0M | 4.04% | 50,100 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $15.8M | 3.99% | 356,532 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $10.9M | 2.76% | 45,000 | Common | SOLE |
| T9224W109 | STVN | STEVANATO GROUP S P A | $10.4M | 2.62% | 565,422 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $9.1M | 2.30% | 63,811 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $8.6M | 2.16% | 113,344 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $4.0M | 1.01% | 101,959 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $3.5M | 0.89% | 514,642 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $3.1M | 0.79% | 75,319 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $2.8M | 0.70% | 382,055 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $2.4M | 0.61% | 71,428 | Common | SOLE |
| 31447E105 | FEMY | FEMASYS INC | $34,891 | 0.01% | 30,606 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.